Endava earnings missed by £0.16, revenue fell short of estimates

Endava reported Q3 EPS of £0.05, missing the £0.21 estimate by £0.16, while revenue of £178.5M also fell short of the £183.68M consensus. The stock closed at £4.00 and is down 19.03% over the past 3 months and 72.79% over 12 months, reflecting weak sentiment after the earnings miss. Analyst revisions remain negative, with 5 downward EPS revisions versus 2 upward revisions in the last 90 days.

Analysis

DAVA’s miss is less important as a standalone quarter than as a confirmation that the business is still in the middle of a downdraft where estimate revisions are lagging the deterioration. When a software/services name is already priced for distress, the key question is whether the revision cycle is nearing exhaustion; here, the skew of recent estimate changes suggests that downward pressure on consensus may continue for another 1-2 reporting cycles rather than bottom immediately. That matters because valuation compression in these names is typically driven more by estimate cuts than by the headline EPS miss itself.

The second-order risk is customer behavior: digital transformation spend is one of the easiest discretionary budgets to defer, so services vendors with exposure to mid-market and project-based work tend to see weaker pipeline conversion before revenue growth visibly rolls over. That creates a lagged earnings-risk profile where backlog quality and booking cadence can deteriorate for several quarters even if headline revenue stabilizes. Competitively, larger IT services peers with stronger offshore leverage and broader enterprise relationships should be better positioned to absorb share if clients consolidate vendors, leaving smaller or more exposed players fighting for lower-margin work.

The market may still be underappreciating how much of the downside can come from gross margin mix rather than demand alone. If utilization stays soft, any recovery in revenue can be offset by lower pricing and bench costs, which means the path back to durable profitability is likely slower than the stock is implying. The contrarian case is that the stock has already de-rated heavily enough that a mild stabilization in bookings could trigger a violent short-covering move, but that is a trading bounce, not a fundamental inflection, unless revisions turn positive again.

Key Decisions for Investors

• Stay short DAVA for 2-6 weeks into the next estimate cycle; the setup favors continued negative revisions. Use a tight stop above the post-earnings range high because any stabilization in bookings could trigger a squeeze.
• Prefer a relative short DAVA vs long a higher-quality IT services peer basket (e.g., EPAM/ACN-type exposure) over an outright short; the pair isolates idiosyncratic revision risk while reducing market beta.
• If looking for a tactical fade, sell out-of-the-money DAVA call spreads into strength over the next 1-3 weeks; implied vol should remain elevated, and upside is capped unless management surprises on bookings.
• Do not average down until there is evidence of positive revision inflection or two consecutive quarters of stabilization; the risk/reward is still unfavorable because earnings revisions remain the dominant driver.